4.6 Review

Leukemia stem cells

期刊

SEMINARS IN CANCER BIOLOGY
卷 20, 期 2, 页码 71-76

出版社

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcancer.2009.12.001

关键词

Leukemia; Leukemia stem cells; Cancer stem cells

类别

资金

  1. National Health and Medical Research Council Australia, Australia/U.S
  2. Ful-bright Commission
  3. Haematology Society of Australia and New Zealand
  4. Royal Brisbane and Women's Hospital Foundation
  5. US National Institute of Health (NIH
  6. Bethesda, MD)
  7. Howard Hughes Medical Institute (Boston, MA)
  8. Leukemia & Lymphoma Society (White Plains, NY)
  9. Myeloproliferative Disorders Foundation (Chicago, IL)

向作者/读者索取更多资源

Leukemia stem cells (LSC) reside within a hierarchy of malignant hematopoiesis and possess the ability to instigate, maintain and serially propagate leukemia in vivo, while retaining the capacity to differentiate into committed progeny that lack these properties. In most cases, LSC appear to share immunophenotypic characteristics with committed hematopoietic progenitors, however have pathologically enhanced self-renewal, mediated through the activation of certain cellular pathways. The presence of a LSC that solely possesses the ability to initiate and sustain leukemia has implications for the treatment of patients with this disease. In this review, we will discuss these issues as well as some of the recent controversies regarding LSC frequency and alternative theories of leukemogenesis. (C) 2009 Published by Elsevier Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据